ID A0A0U1WYF4_9CAUD Unreviewed; 619 AA. AC A0A0U1WYF4; DT 16-MAR-2016, integrated into UniProtKB/TrEMBL. DT 16-MAR-2016, sequence version 1. DT 07-SEP-2016, entry version 4. DE SubName: Full=Uncharacterized protein {ECO:0000313|EMBL:AHY26087.1}; GN ORFNames=812_122 {ECO:0000313|EMBL:AHY25650.1}, 812a_122 GN {ECO:0000313|EMBL:AHY25870.1}, 812F1_122 GN {ECO:0000313|EMBL:AHY26303.1}, K1/420_122 GN {ECO:0000313|EMBL:AHY26519.1}, K1_122 {ECO:0000313|EMBL:AHY26087.1}; OS Staphylococcus phage 812. OC Viruses; dsDNA viruses, no RNA stage; Caudovirales; Myoviridae; OC Spounavirinae; Twortlikevirus; unclassified Twortlikevirus. OX NCBI_TaxID=307898 {ECO:0000313|EMBL:AHY26087.1}; RN [1] {ECO:0000313|EMBL:AHY26087.1} RP NUCLEOTIDE SEQUENCE. RC STRAIN=Host-range mutant 812a {ECO:0000313|EMBL:AHY25870.1}, RC Host-range mutant 812F1 {ECO:0000313|EMBL:AHY26303.1}, Host-range RC mutant K1 {ECO:0000313|EMBL:AHY26087.1}, and Host-range mutant K1/420 RC {ECO:0000313|EMBL:AHY26519.1}; RA Pantucek R., Benesik M., Maslanova I., Varga M., Videnska P.; RT "Lytic effect of Twortlikevirus polyvalent therapeutic bacteriophages RT on Staphylococcus aureus human clinical isolates."; RL Submitted (JAN-2014) to the EMBL/GenBank/DDBJ databases. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; KJ206559; AHY25650.1; -; Genomic_DNA. DR EMBL; KJ206560; AHY25870.1; -; Genomic_DNA. DR EMBL; KJ206561; AHY26087.1; -; Genomic_DNA. DR EMBL; KJ206562; AHY26303.1; -; Genomic_DNA. DR EMBL; KJ206563; AHY26519.1; -; Genomic_DNA. DR RefSeq; YP_009224532.1; NC_029080.1. DR GeneID; 26795684; -. DR KEGG; vg:26795684; -. DR InterPro; IPR032096; DUF4815. DR Pfam; PF16075; DUF4815; 1. PE 4: Predicted; FT DOMAIN 9 611 DUF4815. {ECO:0000259|Pfam:PF16075}. SQ SEQUENCE 619 AA; 68928 MW; 9341FD986B8EBB55 CRC64; MAINFKGSPY LDRFDPSKDR TKVLFNPDRP LQQAELNEMQ SIDQYYLKNL GDAIFKDGDK QSGLGFTLSE DNVLTVNPGY VYINGKIRYY DNDDSVKITG VGKETIGIKL TERIVTPDED ASLLDQTSGV PSYFSKGADR LEEKMSLTVN DPTSATIYTF MDGDLYIQST NAEMDKINKV LAERTYDESG SYKVNGFELF SEGNAEDDDH VSVVVDAGKA YVKGFKVDKP VSTRISVPKS YDLGTAENES TIFNKSNNSI SLANSPVKEI RRVTGQVLIE KERVTRGAQG DGQDFLSNNT AFEIVKVWTE TSPGVTTKEY KQGEDFRLTD GQTIDWSPQG QEPSGGTSYY VSYKYNKRME AGKDYEVTTQ GEGLSKKWYI NFTPSNGAKP IDQTVVLVDY TYYLARKDSV FINKYGDIAI LPGEPNIMRL VTPPLNTDPE NLQLGTVTVL PDSDEAVCIS FAITRLSMED LQKVKTRVDN LEYNQAVNAL DDGAMEGQNP LTLRSVFSEG FISLDKADIT HPDFGIVFSF EDAEATLAYT EAVNQPKIIP GDTTAHIWGR LISAPFTEER TIYQGQASET LNVNPYNIPN KQGVLKLTPS EDNWIDTENV TITEQKTKK //